Innate Immunity Activation Antibody Sampler Kit #52239
Product Information
Kit Usage Information
Protocols
- 4363: Western Blotting, Immunoprecipitation (Agarose)
- 7074: Western Blotting
- 11904: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence
- 11927: Western Blotting, Immunoprecipitation (Magnetic)
- 12390: Western Blotting
- 13014: Western Blotting
- 13647: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Leica® Bond™), Immunohistochemistry (Paraffin)
- 19781: Western Blotting
- 29047: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence*, Flow
- 83186: Western Blotting, Immunofluorescence
Product Description
The Innate Immunity Activation Antibody Sampler Kit provides an economical means of detecting the activation of multiple signaling pathways involved in innate immunity using phospho-specific, cleavage-specific, and control antibodies. The kit contains enough primary antibodies to perform at least two western blot experiments.
Specificity / Sensitivity
Each antibody in the Innate Immunity Activation Antibody Sampler Kit detects endogenous levels of its target protein. Phospho-STING (Ser366) (D7C3S) Rabbit mAb detects STING only when phosphorylated at Ser366. Phospho-IRF-3 (Ser396) (D6O1M) Rabbit mAb detects IRF-3 only when phosphorylated at Ser396. Phospho-IRAK4 (Thr345/Ser346) (D6D7) Rabbit mAb detects IRAK4 only when phosphorylated at both Thr345 and Ser346 and does not react with IRAK4 when phosphorylated at only one of these sites. Phospho-IRF-7 (Ser477) (D7E1W) Rabbit mAb detects IRF-7 only when phosphorylated at Ser477. Phospho-IRF-7 (Ser477) (D7E1W) Rabbit mAb may cross-react with proteins of unknown origin between 100 and 150 kDa. Cleaved-IL-1β (Asp116) (D3A3Z) Rabbit mAb detects mature IL-1β only when cleaved at Asp116.
Source / Purification
Monoclonal and polyclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Pro226 of STING, Lys41 of IRAK4, Pro115 of IRF-7, Asp116 of IL-1β, or recombinant human IRF-3 protein. Phospho-specific antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Ser366 of STING, Ser396 of IRF-3, Thr345/Ser346 of IRAK4, or Ser477 of IRF-7. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.
Background
The innate immune system responds rapidly to pathogens by detecting conserved pathogen-associated molecular patterns (PAMPs) and damage/danger-associated molecular patterns (DAMPs) through pattern recognition receptors (PRRs). There are several families of PRRs. Toll-like receptors (TLRs) are transmembrane PRRs and signal through recruitment of adaptor proteins, including MyD88, which leads to recruitment and phosphorylation of IRAK1 and IRAK4, followed by activation of NF-κB and MAP kinases (1-3). Some TLRs also activate IRFs, which upregulate the type I interferon response. Activation of TLR3 and TLR4 results in phosphorylation and activation of IRF-3, while TLR7, TLR8, and TLR9 lead to activation of IRF-7 (2, 3). STING is a multi-pass ER transmembrane protein that is activated in response to intracellular DNA downstream of DNA-sensing cytoplasmic PRRs, such as DDX41, or by binding the second messenger cyclic-GMP-AMP (cGAMP) produced by cGAS (4-6). Following activation, STING translocates with TBK1 to perinuclear endosomes, leading to phosphorylation and activation of IRF-3 and NF-κB (7, 8). Following activation and translocation, STING gets phosphorylated by ULK1, resulting in STING inactivation and degradation (9). Inflammasomes are cytoplasmic multimeric protein complexes that assemble in response to PAMPs or DAMPs detected by AIM2 or members of the nod-like receptor (NLR) family, such as NLRP3 (10). Inflammasomes activate Caspase-1, which cleaves the IL-1β and IL-18 precursor proteins into the mature forms (10).
- Janssens, S. and Beyaert, R. (2003) Mol Cell 11, 293-302.
- Barton, G.M. and Kagan, J.C. (2009) Nat Rev Immunol 9, 535-42.
- Blasius, A.L. and Beutler, B. (2010) Immunity 32, 305-15.
- Ishikawa, H. and Barber, G.N. (2008) Nature 455, 674-8.
- Zhang, Z. et al. (2011) Nat Immunol 12, 959-65.
- Sun, L. et al. (2013) Science 339, 786-91.
- Zhong, B. et al. (2008) Immunity 29, 538-50.
- Ishikawa, H. et al. (2009) Nature 461, 788-92.
- Konno, H. et al. (2013) Cell 155, 688-98.
- Rathinam, V.A. and Fitzgerald, K.A. (2016) Cell 165, 792-800.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.